Search

Your search keyword '"Kim Rand"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Kim Rand" Remove constraint Author: "Kim Rand"
93 results on '"Kim Rand"'

Search Results

3. Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

4. Digital thErapy For Improved tiNnitus carE Study (DEFINE): Protocol for a randomised controlled trial.

5. Prospective assessment of clinical outcomes of transcatheter aortic valve implantation in a cohort of patients based on their risk profile

6. Evaluación de los resultados en salud del implante valvular aórtico transcatéter en una cohorte de pacientes según su perfil de riesgo

7. Reduced quality of life, more technical challenges, and less study motivation among paramedic students after one year of the COVID-19 pandemic – a survey study

8. EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets

9. Stroke unit demand in Norway – present and future estimates

10. A retrospective survey study of paramedic students’ exposure to SARS-CoV-2, participation in the COVID-19 pandemic response, and health-related quality of life

12. Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications

13. Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L

14. What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19

15. Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010–2015

16. Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol

17. General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys

18. Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst

19. A missing cornerstone in the Norwegian Priority Commission’s weighting scheme – Sub-treatment balancedness is a necessary property for priority setting criteria

20. Censoring Time Trade-off Values at 0 Versus at −1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data?

24. Normal B-cell ranges in infants: A systematic review and meta-analysis

26. Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?

27. Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states

28. Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study

29. Norwegian population norms for the EQ-5D-5L: results from a general population survey

30. Preference Paths and Their Kaizen Tasks for Small Samples

31. Estimating the EQ-5D-5L value set for the Philippines

33. Cross-attribute level effects models for modelling modified EQ-5D-5L health state values: is less still more?

34. Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?

35. Valuation of EQ-5D-3l Health States in Slovenia: VAS based and TTO based Value Sets

36. A retrospective survey study of paramedic students’ exposure to SARS-CoV-2, participation in the COVID-19 pandemic response, and health-related quality of life

37. Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications

38. Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010–2015

39. Valuation of Health States Considered to Be Worse Than Death—An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies

40. Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease

41. The remarkably frequent use of EQ-5D in non-economic research

43. Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol

44. Testing the 'Nonstopping' Time Trade-Off: Is It Better Than the Composite Time Trade-Off?

45. A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms

46. Stroke incidence in the young: evidence from a Norwegian register study

47. Choice Defines QALYs

48. Comparison of health state values derived from patients and individuals from the general population

49. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

50. EQ-5D-5L Valuation for the Malaysian Population

Catalog

Books, media, physical & digital resources